Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.8ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BF.8ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BF.8SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BF.8SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BF.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.74ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.2.74ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.2.74SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.74SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.2.74EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.74NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.74NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.12ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.2.12ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.2.12SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.12SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.2.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BM.3ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
BM.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BM.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BM.3SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BM.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BM.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BM.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.28ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.5.2.28ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.5.2.28SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.28SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.5.2.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.28NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.62ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.5.2.62ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.5.2.62SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.62SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.5.2.62EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.62NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used